Ongoing Research Support:

1. ‘WHO-ICMR SOLIDARITY TRIAL PLUS –-India titled “An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are receiving the local standard of care” (ICMR )
2. “Prevalence of Select Sexually Transmitted infections and Reproductive Tract infections among selected High Risk Groups: MSM, FSW, IDU in India” (NACO, GoI)
3. HIV Sentinel Surveillance (Western and Central India): Program-research (NACO, GoI)
4. ICMR/SII-COVOVAX: A phase 3, observer-blind, randomized, controlled study to determine the safety and immunogenicity of Covovax [Sars-CoV-2 recombinant spike protein nanoparticle vaccine (Sars-CoV-2 rS) with Matrix-M1™ adjuvant] in Indian adults., PI /Co-PI (ICMR )

Completed Research Support: (last 7 years only)

1. The ART Impact Evaluation- India Study (ARTIE-India): Evaluation of Impact of Antiretroviral Therapy under the National AIDS Control Programme in India’ (2017-2020)
2. An assessment of feasibility of operationalization of ‘Early or Immediate ART’ to HIV infected partner as a combination intervention among HIV sero-discordant couples in India.(2016 -2019)
3. In-country data validation for Elimination of mother-to-child transmission of HIV and Syphilis in Six Indian states, 2017. Phase I: Maharashtra (2017)
4. HPTN 052:A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care alone to prevent the Sexual Transmission of HIV-1 in Sero-discordant Couples. (2011-2016)
5. Utility of Prevention-of-Mother-to-Child HIV Transmission Program Data for HIV Surveillance (2015 and 2017)
6. Relation Between Genetic Markers of Drug resistance and Susceptibility Profile of N. gonorrhoeae strains’- A study in 4 centres in India (2014-2015)
7. ACTG 5282:A Randomized, Phase II Trial to Compare an HPV Test-and-Treat Strategy to a Cytology based Strategy for Prevention of CIN 2+ in HIV-infected Women (2013-2013)

1. Phoenix Leading Lady Award for Excellence in Research in Maharashtra, March 2017
2. Selected as an ICMR fellow for the “Collaborative Indo-Swedish Public Health Initiative for Research Excellence” (INSPIRE) Indo-Swedish Program in 2011-12
3. “Young Achievers Award for Women”: for contributions in the field of Health and Medicine in Pune City over the last decade. 4th January 2003 in Pune, All India Women’s Conference
4. “Best Participant award”: WHO Disease Burden Workshop 2001.
5. “A. C. Parikh award for Best Case Paper presentation”, presented by Indian Association of Dermatologists and Venereologists Maharashtra Branch 1992.
6. Scientific Breakthrough of 2011”: The paper “Prevention of HIV-1 Infection with Early Antiretroviral Therapy” published in New England Journal of Medicine July 18 2011, was identified as Scientific Breakthrough of 2011 in December 2011 by the prestigious journal ‘Science’. I am a Co-Author on the mast head of this paper. This paper has become a citation classic with nearly 5000 citations

She is an experienced clinician-researcher, a leader and communicator with strong technical, grant-writing, project management-implementation and administrative skills. She has successfully written, received and implemented many national and internationally funded extramural research grants and currently manages large project budgets and leads collaborations with multiple partner institutes in India (ICMR and non-ICMR).

As ‘Clinical Research Site Leader’ and later on the ‘Principal Investigator’ (2015) of the NIH USA funded NARI Clinical Trial Unit (CTU) and she led many clinical trials. As Investigator of Record and later the grantee PI, for the Phase III Randomised Controlled Clinical Trial studying antiretroviral treatment for HIV prevention among HIV discordant couples (HPTN 052) with 5 year follow up, she played a major role in setting up systems to ensure good implementation of clinical trials at ICMR-NARI. This study led to a change in treatment guidelines for HIV in India.

For over two decades she has led clinical-epidemiological studies in HIV, STI’s, HPV, HIV& Cancer, Clinical Trials for HIV prevention and treatment (antiretrovirals) and most recently COVID 19. She conducted the first population based HIV-Cancer registry match study in India outlining the high risk for various cancers among persons with HIV and demonstrated a significant anal prevalence of high risk HPV among Indian women with HIV.  She was the clinical-lead of a research clinic providing care for sexually transmitted infections and HIV until a few years ago.  She contributed to ICMR’s research response to the COVID crisis, by setting up the Solidarity Trial Network in India for COVID treatment and also led the implementation of one of the ICMR supported Phase 2/3 trials for a vaccine against SARS-COV2 which has just received emergency authorization in India.

In addition to her contributions to HIV surveillance, Dr. Godbole has contributed to India’s National Programme and commitment to eliminate Mother to Child Transmission of HIV and Syphilis in 2020 as an invited member of the National Core Group formulated by the Ministry and by conducting a unique Data Validation study that identified key gaps and action points for NACO and RMNCHA+ programs. She also recently completed the first evaluation of the impact of the ‘Free antiretroviral treatment (ART) program’ of the Government of India, and set up a strong nationwide collaboration for the same. She is part of many technical working groups and committees which advise the National AIDS Control Program in India. She is currently involved as a Co-chair in developing an integrated STI surveillance in India.

Membership of Professional / Advisory Bodies / Committees:

National Level technical and advisory committees constituted by National AIDS Control Organization (MoH&FW) GOI for the National AIDS Control Program (NACP)

1. WHO Technical Advisory Group (TAG) on Sexually Transmitted Infection (STI) research priority setting- 2021
2. WHO and UK Government ‘Round Table on the international clinical trials infrastructure’- 2021
3. Technical Resource Group for Female Sex Workers (FSW), Member 2021 onwards
4. Technical Resource Group on Surveillance and Epidemiology Member- 2021 onwards
5. Co-Chair, National Sub-Group for STI Surveillance, 2021 onwards
6. National Sub-Group for HIV Burden Estimations - 2021 onwards
7. National Working Group- District Level HIV Estimations 2019-20,
8. National Working Group- District Level HIV Estimations 2019-20,
9. Technical Resource Group for HIV Estimations 2017-18- Member

10. National Consultation-Elimination of Mother to Child Transmission of HIV -Private Sector participation, -Member
11. National Core Group on Elimination of Mother to Child Transmission of HIV and Syphilis
12. Subcommittee for development of Verification and Validation protocols for Elimination of Mother to Child Transmission of HIV and Syphilis (EMTCT) NACO MoH&FW, GOI: Member
13. Technical Resource Group for Prevention of Parent to Child Transmission of HIV, NACO, MoH&FW, GOI- Member
14. National Strategic Plan (2017-24) development (NACO road map): for prevention and elimination of HIV/AIDS in India- Technical Sub-Committee Monitoring, Evaluation and Surveillance: Member
15. National Strategic Plan (2017-24) development: NACO road map for prevention and elimination of HIV/AIDS in India constituted by NACO MoH&FW, GOI:  Technical Sub-Committee for a. EMTCT of HIV & b. HIV-TB:  Member
16. National HIV Testing Guidelines Writing Group: Technical Expert and Sub Committee member Dec 2015 – July 2016. (The guidelines were published in Dec 2016)
17. Regional STI Centre National Mentoring Committee: Committee was constituted in September 2012- Member
18. NACO Technical Resource Group’s for NACP IV planning: Member of  following sub-groups-
19. Sexually Transmitted Infections Working group and STI Surveillance
20. Research and Evaluation: Strategic Information Management Unit
21. Expert consultation -Newer Methods of Surveillance and HIV estimations in India, 2018
22. Expert Consultation for HIV Surveillance and Estimations 2016: Member and Resource Person.
23. Expert Consultation for HIV Testing: WHO and NACO Nov 2015 Member
24. Expert Consultation for the Development of a Strategy towards Elimination of Congenital Syphilis (ECS) 2013 : Member

   WHO, UNAIDS & GOI

Ethics Committees

• Ethics Committee: National Institute of Virology –Member
• Ethics Committee: UDIRT, Maharashtra University of Health Sciences (MUHS), Nashik, Maharashtra. February 2006-8

Other International:

1. Prevention Science Working Group- HIV Prevention Trial Network, DAIDS NIH USA (completed)
2. Women’s Health Committee, AIDS Clinical Trials Network, DAIDS NIH USA (completed)
3. Women at Risk (WaTR) Scientific Committee of HIV Prevention Trial Network, DAIDS NIH USA (completed)
4. Performance Evaluation Committee, AIDS Clinical Trials Network, DAIDS NIH USA (completed)

Professional Bodies:

1. Indian Association of Preventive & Social Medicine (IAPSM)- Life member
2. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) - Life member
3. Indian Medical Association- Life Member

*Actively involved in clinical care of persons at risk of or with HIV as a clinician until recently

Publications:

1. “Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses”.- WHO Solidarity Trial Consortium

The Lancet, www.thelancet.com Published online May 2, 2022 https://doi.org/10.1016/S0140-6736(22)00519-0

2. “Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies”.  Feixue Wei,Ningshao Xia, Rebeca Ocampo, Marc T Goodman, Nancy A Hessol, Beatriz Grinsztejn, Ana P Ortiz, Fanghui Zhao, Erna M Kojic, Rupert Kaul,Isabelle Heard, Imran O Morhason Bello, Anna-Barbara Moscicki, Alexandra de Pokomandy, Joel M Palefsky, Luana L S Rodrigues, Racheal S Dube Mandishora, Reshmie A Ramautarsing, Silvia Franceschi, Sheela V Godbole, Fernanda K Tso, Lynette J Menezes, Chunqing Lin, Gary M Clifford  The Journal of Infectious Diseases, 23 March 2022. jiac108, https://doi.org/10.1093/infdis/jiac108
3. “A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282”. Wilkin T, Chen H, Sahasrabuddhe V, Matining R, Mngqibisa R, Chinula L, Mbilizi Y, Magure T, Omoz-Oarhe AE, Rassool M, Riviere C, Bhosale R, Godbole S, Naranjo R, Coombs R, Michelow P, Godfrey C, Firnhaber C.Clin Infect Dis. 2022 Mar 16:ciac213. doi: 10.1093/cid/ciac213. Online ahead of print. PMID: 35294524

4. “Quantifying inadvertent data-duplication- findings from validation of antenatal-registration and HIV testing data-sets from an Indian state” Sheela Godbole , Shweta Chidrawar , Suvarna Sane, Yashika Bansal , Asha Hegde , Shilpa Bembalkar , Suchit Kamble , Megha Mamulwar , Shrikala Acharya , Vijay Bawiskar , Laxmi Ramakrishnan , Yujwal Raj , Raman Gangakhedkar, Ashok Kumar, D C S Reddy, Arvind Pandey, Tobi Saidel, Naina Rani, Nicole Seguy, K S Sachdeva .   International Journal of Epidemiology, September 2021, Vol 50, Issue Supplement _1

5. “Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052” Maganizo B Chagomerana, Mina C Hosseinipour, Jose Henrique Pilotto, Sharlaa Badal-Faesen, Mulinda Nyirenda, Emily Shava, Sheela V Godbole, Victor Akelo, Suwat Chariyalertsak, Ravindre Panchia and Myron Cohen. International Journal of STD & AIDS 2021 Jul DOI: 10.1177/09564624211030368.
6. “District-level HIV estimates using the spectrum model in five states of India, 2017” Kumar P, Sahu D, Rajan S, Mendu VV, Das C, Kumar A, Chandra N, Camara B, Rai S, Arumugam E, Godbole SV, Singh SK, Kant S, Pandey A, Reddy DC, Mehendale S.Medicine 2021;100:28(e26578).
7. “Repurposed antiviral drugs for COVID-19–interim WHO SOLIDARITY trial results” The members of the writing and steering committees (H. Pan, R. Peto, A.-M. Henao-Restrepo, M.-P. Preziosi, V. Sathiyamoorthy, Q. Abdool Karim, M.M. Alejandria, C. Hernández García, M.-P. Kieny, R. Malekzadeh, S. Murthy, K.S. Reddy, M. Roses Periago, P. Abi Hanna, F. Ader, A.M. Al-Bader, A. Alhasawi, E. Allum, A. Alotaibi, C.A. Alvarez-Moreno, S. Appadoo, A. Asiri, P. Aukrust, A. Barratt-Due, S. Bellani, M. Branca, H.B.C. Cappel-Porter, N. Cerrato, T.S. Chow, N. Como, J. Eustace, P.J. García, S. Godbole, E. Gotuzzo, L. Griskevicius, R. Hamra, M. Hassan, M. Hassany, D. Hutton, I. Irmansyah, L. Jancoriene, J. Kirwan, S. Kumar, P. Lennon, G. Lopardo, P. Lydon, N. Magrini, T. Maguire, S. Manevska, O. Manuel, S. McGinty, M.T. Medina, M.L. Mesa Rubio, M.C. Miranda-Montoya, J. Nel, E.P. Nunes, M. Perola, A. Portolés, M.R. Rasmin, A. Raza, H. Rees, P.P.S. Reges, C.A. Rogers, K. Salami, M.I. Salvadori, N. Sinani, J.A.C. Sterne, M. Stevanovikj, E. Tacconelli, K.A.O. Tikkinen, S. Trelle, H. Zaid, J.-A. Røttingen, and S. Swaminathan)   New England Journal of Medicine(NEJM) online- 2^nd December 2020  Print – February 2021

8. “Findings from the 2017 HIV estimation round & trend analysis of key indicators 2010-2017: Evidence for prioritising HIV/AIDS programme in India” Damodar Sahu , Pradeep Kumar , Nalini Chandra, Shobini Rajan, D.K. Shukla, S. Venkatesh, Saritha Nair, Anil Kumar, Jitenkumar Singh, Srikanth Reddy, Sheela Godbole, Elangovan, M.K. Saha, Sanjay Rai, P.V.M. Lakshmi, T. Gambhir, Savina Ammassari, Deepika Joshi, Amitabh Das, Poonam Bakshi , Sabyasachi Chakraborty, Amol Palkar, S.K. Singh, D.C.S. Reddy, Shashi Kant, Arvind Pandey & M. Vishnu Vardhana Rao. Indian J Med Res 151, June 2020, pp 562-570 DOI: 10.4103/ijmr.IJMR_1619_19

9. “Persons living with HIV continue to present late for care: A trend analysis from 2011 to 2015”. Kadam AV, Bembalkar SC, Panchal NU,Mamulwar MS, Shete AV, Godbole SV.*.  Indian J Sex Transm Dis 2019; 40:133-8.

10. "Evaluation of key survey components of bio-behavioral surveillance among HIV high-risk subpopulation in Western India" Brahme RG, Godbole SV, Gangakhedkar RR, Sachdeva KS, Verma V, Risbud AR. Indian J Public Health 2019;63:305-12.

11. “Optimization of extraction of genomic DNA from archived dried blood spot (DBS): potential application in epidemiological research & bio banking”. Kumar A, Mhatre S, Godbole S et al. Gates Open Research 2019, 2:57   [version 3; peer review: 2 approved, 1 approved with reservations]  (https://doi.org/10.12688/gatesopenres.12855.3)

12. “Declining Trends in HIV Prevalence Among Women Attending Antenatal Care Clinics Obfuscate the Continued Vulnerability of Adolescent Girls in Maharashtra, India (2005–2017)”
    Brahme, Radhika; Godbole, Sheela*; Sonawale, Suvarna; Kadu, Chitra; Yadav, Rajesh; Dulhani, Nisha; Lokhande, Amit; Kumar, Pradeep; Deoraj, Pramod; Acharya, Shreekala; Rajan, Shobini; Venkatesh, Srinivas JAIDSJournal of Acquired Immune Deficiency Syndromes, September 1, 2019,82(1):e13-e17 Letters to the Editor

13. “Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis”. Chunqing Lin, Jiri Slama, Paula Gonzalez, Marc T Goodman, Ningshao Xia, Aimée R Kreimer, Ting Wu, Nancy A Hessol, Yurii Shvetsov, Ana P Ortiz, Beatriz Grinsztejn, Anna-Barbara Moscicki, Isabelle Heard, María del Refugio González Losa, Erna M Kojic, Maarten F Schim van der Loeff, Feixue Wei, Adhemar Longatto-Filho, Zizipho A Mbulawa, Joel M Palefsky, Annette H Sohn, Brenda Y Hernandez, Katina Robison, Steve Simpson Jr, Lois J Conley, Alexandra de Pokomandy, Marianne A B van der Sande, Racheal S Dube Mandishora, Lays P B Volpini, Alessandra Pierangeli, Byron Romero, Timothy Wilkin, Silvia Franceschi, Carmen Hidalgo-Tenorio, Reshmie A Ramautarsing, Ina U Park, Fernanda K Tso, Sheela Godbole, Kathleen W M D’Hauwers, Borek Sehnal, Lynette J Menezes, Sandra A Heráclio, Gary M Clifford. Lancet Infectious Diseases Published online June 13, 2019 http://dx.doi.org/10.1016/S1473-3099(19)30164-1   
14. “Understanding racial diversities in Kaposi's sarcoma”. Sheela Godbole, Manisha Ghate, Sanjay Mehendale. Indian Journal of Medical Research 149, March 2019, pp 319-321 DOI:10.4103/ijmr.IJMR_2164_18IJMR_2164_18 
15. “Functional invariant Natural Killer T cells secreting cytokines are associated with non-progressive HIV-1 infection but not with suppressive ART” Singh D, Ghate M, Godbole S, Kulkarni S and Thakar M.  Frontiersin Immunology, (section T Cell Biology). 9:1152. Doi:10,3389/fimmu.2018.01152. 24 May 2018

16. “Use of computer-assisted personal interviewing and information management system in a survey among HIV high-risk groups in India: Strengths, weaknesses, opportunities, and threats analysis” Brahme R, Godbole S, Gangakhedkar R, Sachdeva KS, Verma V, Risbud A. Indian J Community Med 2018;43:107-12

17. “Productively infected CD4+ cells express higher Human telomerase reverse transcriptase levels indicating a possible mechanism of persistence in HIV infection” Poonam Suryawanshi, Sheela Godbole, Jyoti Pawar. Madhuri Thakar , Ashwini Shete Journal of Microbiology and Immunology. First published: 25 March 2018 https://doi.org/10.1111/1348-0421.12585
18. “Differing HIV vulnerability among female sex workers in a high HIV burden Indian state” Mamulwar M, Godbole S*, Bembalkar S, Kamble P, Dulhani N, Yadav R, et al. (2018). PLoS ONE 13(2): e0192130. https://doi.org/10.1371/journal.pone.0192130
19. “HIV Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: HPTN 052”   Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C^,  Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S , Eron JJ, Gallant JE, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Pilotto JH, Kumwenda J, Akelo V, Godbole SV, Santos BR, Grinsztejn B, Panchia R, Chariyalertsak S, Makhema J, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH.  Journal of Acquired Immune Deficiency Syndromes (JAIDS) December 2017.DOI 10.1097/QAI.0000000000001623
20. “Antibiotic susceptibility pattern of Neisseria gonorrhoeae strains isolated from five cities in India during 2013–2016” Sangeeta V. Kulkarni, Manju Bala Syeeda A. Muqeeth [...] Sheela V Godbole*  Journal of Medical Microbiology Dec 2017
21. “Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity-mediating antibodies in HIV-infected Indian individuals”. Nehul S, Kulkarni A, Pawar S, Godbole S, Ghate M, Thakar M. Infect Dis (Lond). 2017 Aug 4:1-9. doi: 10.1080/23744235.2017.1361547.
22. “Association of HIV diversity and virologic outcomes in early antiretroviral treatment” HPTN 052.” Palumbo PJ,Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Gonçalves de Melo M, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman Sh, Fogel JM. PLoS One. May 2017.
23. “Virologic outcomes in early antiretroviral treatment: HPTN 052”. Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, Godbole SV, Chotirosniramit N, Santos BR, Shava E, Mills LA, Panchia R, Mwelase N, Mayer KH, Chen YQ, Cohen MS, Fogel JM HIV Clinical Trials e-pub April 7 2017.
24. “Low immune activation is associated with higher frequencies of central memory T cell subset in a cohort of Indian long term non-progressors”. Saxena V, Bichare S, Singh D, Ghate M, Godbole S, Kulkarni S, Gangakhedkar R, Paranjape R, Thakar M. AIDS Res Hum Retroviruses 2017 Feb;33 (2):121-125. doi:10.1089/AID.2016.0210.

25. “CD1d restricted Natural killer T cells are preserved in Indian long term non progressors (LTNPs)” Singh D, Ghate M, Godbole S, Kulkarni S, Thakar M Feb  2017 JAIDS J Acquir Immune Defic Syndr. doi:10.1097/QAI.0000000000001322

26. “Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein”.Kulkarni A, Kurle S, Shete A, Ghate M, Godbole S, Madhavi V, Kent SJ, Paranjape R, Thakar M. Frontiers in Immunology 8(14)January 2017. DOI: 10.3389/fimmu.2017.00005

27. “Development of IFN- secretory ELISPOT based assay for screening of ADCC responses.” Shete A, Suryawanshi P, Chavan C, Kulkarni A, Godbole S, Ghate M and Thakar M. Journal of Immunological methods 2016 Dec 5.

28. “Fitting HIV Prevalence 1981 Onwards for Three Indian States Using the Goals Model and the Estimation and Projection Package.” Bhatnagar T, Dutta T, Stover J, Godbole S, Sahu D, Boopathi K, Bembalkar S, Singh KJ, Goyal R, Pandey A, Mehendale SM.                         PLoS One. 2016 Oct 6;11(10):e0164001.

29. "HIV and Cancer Registry Linkage identifies a Substantial Burden of Cancers in Persons with HIV in India". Sheela V Godbole et al Medicine 95: 37, September 2016

30. “Antiretroviral Treatment for Prevention of HIV Transmission: The Final Results of the HIV Prevention Trials Network (HPTN) 052 Trial”.  M S. Cohen,  Q. Chen, M McCauley, T. Gamble, M.C.Hosseinipour, N. Kumarasamy, J.G. Hakim, J.Kumwenda, B Grinsztejn, J.H.S. Pilotto, S.V. Godbole., S.Chariyalertsak, B.R. Santos, K H. Mayer, I F. Hoffman, S.H. Eshleman, E Piwowar-Manning, L. Cottle, X.C. Zhang, J. Makhema, L.A. Mills, J. Eron, J. Gallant, D.Havlir, S. Swindells, V.Elharrar, D Burns, T.E.Taha, K.Nielsen-Saines, D Celentano, M. Essex, S.E. Hudelson, A.D.Redd.and T. R. Fleming, for the HPTN 052 Study Team*  New England Journal of Medicine  18 July 2016 online first   DOI: 10.1056/NEJMoa1600693

31. "HIV infected CD4+ T cells use T-bet dependent pathway for production of IL-10 upon antigen recognition". Scandinavian Journal of Immunology 83(4):288-296 May 2016 DOI: 10.1111/sji.12422. Shete A, Suryawanshi P, Godbole S, Pawar J, Paranjape R, Thakar M

32. “HIV drug resistance in adults failing early antiretroviral treatment”. JAIDS Journal of Acquired Immune Deficiency SyndromesFebruary 2016 DOI: 10.1097    Fogel, Jessica M.; Hudelson, Sarah E.; Ou, San-San; Hart, Stephen; Wallis, Carole; Morgado, Mariza G.; Saravanan, Shanmugam; Tripathy, Srikanth; Hovind, Laura; Piwowar-Manning, Estelle Sabin, Devin; McCauley, Marybeth; Gamble, Theresa; Zhang, Xinyi Cindy; Eron, Joseph J.; Gallant, Joel E.; Kumwenda, Johnstone; Makhema, Joseph; Kumarasamy, Nagalingeswaran; Chariyalertsak, Suwat; Dr.; Hakim, James; Badal-Faesen, Sharlaa; Akelo, Victor; Hosseinipour, Mina C.; Santos, Breno Riegel; Godbole, Sheela V; Pilotto, Jose Henrique; Grinsztejn, Beatriz; Panchia, Ravindre ; Mayer, Kenneth H.; Chen, Ying Q.; Cohen, Myron S.; Eshleman, Susan H

33. “Fallacy of Using Odds Ratio as A Measure Of Association In Prospective Studies.” Asian J Sc Tech. 2015; 6(11):1990-92 30 Nov 2015. Rajneesh K Joshi, Monil Anurag Khera and Sheela V. Godbole

34. “Predictors of Bisexual Behaviour among MSM Attending Intervention Sites May Help in Prevention Interventions for This Bridge to the Heterosexual Epidemic in India: Data from HIV Sentinel Surveillance” Godbole S,Sane S, Kamble P, Raj Y, Dulhani N, et al. (2014  PLoS ONE 9(9):  doi: 10.1371/journal.pone.0107439

35. “Prevalence of anal Human papillomavirus (HPV) infection among HIV-infected women from India.” Sheela V. Godbole, Arati K. Mane, Shweta R. Chidrawar, Usha R. Katti, Shubhangi Kalgutkar, Prachi V.Athavale, Jyoti S. Pawar, Manisha M. Ratnaparkhi, Mallika Alexander, Arun R. Risbud, Ramesh S.Paranjape,   JAIDS Journal of Acquired Immune Deficiency Syndromes Published Ahead of Print  a DOI: 10.1097/QAI.0000000000000328    5th Sep 2014

36. “Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial”   B Grinsztejn, M Hosseinipour, H Ribaudo, S Swindells, J Eron, Y Chen, L Wang, San-San Ou, M Anderson, M McCauley, T Gamble, N Kumarasamy, J Hakim, J Kumwenda, J H S Pilotto, S V Godbole, S Chariyalertsak, M Gonçalves de Melo, K H Mayer, S H Eshleman, E Piwowar-Manning, J Makhema, L Mills, R Panchia, I Sanne, J Gallant, I Hoff man, T E Taha, K Nielsen-Saines, D Celentano, M Essex, D Havlir, M S Cohen, and the HPTN 052-ACTG Study Team. Lancet Infectious Diseases,Volume 14, Issue 4, Pages 281 - 290, April 2014 http://dx.doi.org/10.1016/S1473-3099(13)70692-

37. “Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples” Rochelle P. Walensky, M.D., M.P.H., Eric L. Ross, B.A., Nagalingeswaran Kumarasamy, M.B., B.S., Ph.D., Robin Wood, D.Sc., Farzad Noubary, Ph.D., A. David Paltiel, Ph.D., M.B.A., Yoriko M. Nakamura, B.A., Sheela V. Godbole, M.D., Ravindre Panchia, M.B., B.Ch., Ian Sanne, M.B., B.Ch., D.T.M.&H., Milton C. Weinstein, Ph.D., Elena Losina, Ph.D., Kenneth H. Mayer, M.D., Ying Q. Chen, Ph.D., Lei Wang, Ph.D., Marybeth McCauley, M.P.H., Theresa Gamble, Ph.D., George R. Seage, III, D.Sc., M.P.H., Myron S. Cohen, M.D., and Kenneth A. Freedberg, M.D.N Engl J Med 2013;369:1715-1725October 31, 2013

38. “Self-Report of STI Symptoms, Inconsistent Condom use and Condom Nonuse are Poor Predictors of STI Prevalence among Men who have Sex with Men”. Nagarajan K, Godbole S*, Ramakrishnan L, Mainkar MK, Ramesh S, Deepika Ganju Ramesh S Paranjape (2013) Journal of AIDS & Clinical Research4:212. doi:4172/2155-6113.1000212 2013

39. ‘Risk reduction and perceived collective efficacy and community support among female sex workers in Tamil Nadu and Maharashtra, India: the importance of context.’ Mohua Guha, Angela Baschieri, Shalini Bharat,Tarun Bhatnagar, Suvarna Sanjay Sane, Sheela V Godbole, Saravanamurthy P S,Mandar Keshav Mainkar, Joseph Williams, Martine Collumbien. JECH Online First, published on July 3, 2012 as 10.1136/jech-2011-200562

40. ‘Current Status of Research on HIV Epidemic, Pathogenesis, Management and Prevention in India.’ Ramesh S. Paranjape, Madhuri R. Thakar, Manisha V. Ghate and Sheela V. Godbole. Proceedings of the National Academy of Sciences, India Section B 2012; 82(1): 167-180

41. ‘Sexually Transmitted Infections and Risk Behaviors among Transgender persons (Hijras) of Pune, India’. Sahastrabuddhe S, Gupta A, Stuart E, Godbole S, Ghate M, Sahay S, Gangakhedkar R, Risbud A, Divekar A, Bollinger R, Mehendale S. J Acquir Immune Defic Syndr 2012 Jan 1; 59(1):72-8.

42. “Prevention of HIV-1 Infection with Early Antiretroviral Therapy.” Myron S. Cohen, Ying Q. Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James G. Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, Jose H.S. Pilotto, Sheela V. Godbole., Sanjay Mehendale, Suwat Chariyalertsak, Breno R. Santos, Kenneth H. Mayer, Irving F. Hoffman, Susan H. Eshleman, Estelle Piwowar-Manning, Lei Wang, Joseph Makhema, Lisa A. Mills, Guy de Bruyn, Ian Sanne, Joseph Eron, Joel Gallant, Diane Havlir, Susan Swindells, Heather Ribaudo, Vanessa Elharrar, David Burns,Taha E. Taha, Karin Nielsen-Saines, David Celentano, Max Essex, and Thomas R. Fleming, for the HPTN 052 Study Team* New England Journal of Medicine 2011, 10.1056/NEJMoa1105243) July 18, 2011, at NEJM.org.

43. “Impact of Targeted Interventions on Heterosexual Transmission of HIV in India.” Rajesh Kumar, Sanjay M Mehendale, Samiran Panda, S Venkatesh, Pvm Lakshmi, Manmeet Kaur, Shankar Prinja, Tarundeep Singh, Navkiran K Virdi, Pankaj Bahuguna, Arun K Sharma, Samiksha Singh, Sheela V Godbole, Arun Risbud, Boymkesh Manna, V Thirumagal, Tarun Roy, Ruchi Sogarwal, Nilesh D Pawar. BMC Public Health 2011, 11:549

44. “Mortality in HIV infected individuals in Pune, India.” Manisha Ghate, Swapna Deshpande, Srikanth Tripathy, Sheela Godbole, Madhura Nene, Madhuri Thakar, Arun Risbud, Robert Bollinger & Sanjay Mehendale. Indian J Med Res 133, April 2011, pp 414-420

45. “Stigmatizing attitudes and low levels of knowledge but high willingness to participate in HIV Management: A community-based survey of pharmacies in Pune, India.” Amita Gupta, Suvarna S Sane, Ajay Gurbani, Robert C Bollinger, Sanjay M Mehendale, Sheela V Godbole. BMC Public Health 2010, 10:51

46. “Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts.”Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S, Thakar M, Risbud A, Bollinger R, Mehendale S. International Journal of Infectious Diseases.(2009)13, e1-e8

47. “HIV Infection in India : Epidemiology, molecular epidemiology and pathogenesis.” Samir Lakhashe, Madhuri Thakar, Sheela Godbole, Srikanth Tripathy and Ramesh Paranjape.Journal of Biosciences Nov 2008; 33 (4) : 515-525

48. “Biomedical research on HIV/AIDS in India.”Sheela Godbole& Sanjay Mehendale published on the web at infochangeindia.org in Februay 2008.

49. “Declining HIV incidence among patients attending Sexually transmitted Infection Clinics in Pune, India.” Sanjay M Mehendale, Nikhil Gupte, Ramesh Paranjape, Amita Gupta, Radhika Brahme, Rewa Kohli, Neelam Joglekar , Sheela V Godbole, Smita N Joshi Manisha V Ghate, Seema Sahay, B Kishore Kumar, Raman R Gangakhedkar,  Arun R Risbud, Ron Brookemeyer, Robert C Bollinger  J Acquir ImmuneDefic Syndr, Aug 15 2007 (45),5, 564-569

50. “Issues in managing and coordinating clinical research in India.”Godbole, S.,& Ghate, M. (2006).  Research Practitioner, 7(6), 219-220

51. “Same sex behaviour and high rates of HIV among men attending sexually transmitted infection clinics in Pune, India, 1993-2002.” Amita Gupta, Shruti Mehta, Sheela V Godbole, Seema Sahay, Louise Walshe, Steven J reynolds, Manisha Ghate, Raman R Gangakhedkar, Anand Divekar, Arun R Risbud, Sanjay M Mehendale, Robert C Bollinger J Acquir ImmuneDefic Syndr epub Oct 2 2006

52. “High Rates of Syphilis among STI Patients are Contributing to the Spread of HIV-1 In India.” J Reynolds, Arun R. Risbud, Mary.E. Shepherd, Anne M. Rompalo, Manisha V. Ghate, Sheela V. Godbole, Smita N Joshi, Anand D Divekar, Raman R. Gangakhedkar, Robert C. Bollinger, and Sanjay M Mehendale. Sex Transm Infections 2006;82:121-126

53. “Rate of hospitalization and inpatient care costs for HIV-1 infected persons in Pune, India.” Ghate MV, Tripathy SP, Kumar BK, Godbole SV, Chitakke A, NyanirguneP,Thakar MR, Gangakhedkar RR, Divekar AD, Risbud AR, Bollinger RC, Mehendale SM. Nat Med J India 2006; 19(1):10-14

54. “Low HIV incidence among married serodiscordant couples in Pune, India.” Mehendale S M, Ghate M V, Kumar BK, Sahay S, Gamble TR, Godbole SV, Thakar MR, Kulkarni SS, Gupta A, Gangakhedkar RR, Divekar AD, Risbud AR, Paranjape RS, Bollinger RC, J Acquir ImmuneDefic Syndr 2006; 41(3): 317-373

55. “High HIV Prevalence Among a High-Risk Subgroup of Women Attending Sexually Transmitted Infection Clinics in Pune, India.” Shruti H Mehta, Amita Gupta, Seema Sahay, Sheela VGodbole, Smita N Joshi, Steven J Reynolds, David D Celentano, Arun Risbud, Sanjay M Mehendale, Robert C Bollinger. J Acquir ImmuneDefic Syndr. 2006 Jan; 41(1):75-80

56. “Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India.”Joshi SN, Katti U, Godbole S, Bharucha K, B KK, Kulkarni S, Risbud A, Mehendale S.Trans R Soc Trop Med Hyg. 2005 Oct; 99(10):769-74

57. “HIV/AIDS epidemic in India: risk factors, risk behaviours and strategies for prevention and control.”Sheela Godbole& Sanjay Mehendale Indian J Med Res. 2005 Apr;121(4):356-68

58. “Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.” R Kairon, S Godbole, S Kulkarni, M Ghate, S Sane, A Shrotri, K Bharucha, S Mehendale, A Risbud. Int J Infect Dis. 2004 Jul; 8(4):251-2

59. “Agenda for Action: Research Priorities in HIV/AIDS in Maharashtra, India.”
    1. A report for Avert Society Maharashtra: a Joint project of NACO, Govt. of Maharashtra and USAID. Facilitators and Editors: Dr. Seema Sahay and Sheela Godbole
60. “Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings”.Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J,Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W,Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG; PEARLS study team of the ACTG. PLoS Med.2012 Aug;9(8):e1001290. Epub 2012 Aug 14. PMID: 22936892, PMCID: PMC3419182
    1. *As a Study Team Member

61. Galvanizing Evidence for HIV Management: A Consultative Meet (NARI, Pune. 27-29 Jan 2011). A report compiled by Dhayarkar S, Krishnan S, Alexander M, Ghate M, Godbole S, Gangakhedkar RR, Tripathy SP. NARI Bulletin April 2011; vol 2, Iss 2, pp 1-8.

62. Early ART (antiretroviral therapy) can prevent Sexual Transmission of HIV to uninfected partner and benefit the infected person as well": Results from the HPTN 052 Study provide a prevention option that seems like an optimal use of antiretroviral drugs for prevention! Godbole S, NARI Bulletin Oct 2011, Vol 2, Iss 4, pp 8-11.

Books and Reports and Guidelines

63. COVID-19 PANDEMIC (History, Science & Society), Chapter 5 Arrows in the Quiver: Prevention & Treatment Pages 66-85 Dr. Samiran Panda & Dr. Sheela Godbole, Published by: The Director General, Publications Division Ministry of Information and Broadcasting, Government of India, Soochna Bhawan, CGO Complex, Lodhi Road, New Delhi 03, http://www.publicationsdivision.nic.in
64. Impact Evaluation of Antiretroviral Treatment Program in India. Report Commissioned by National AIDS Control Organization (NACO) Ministry of Health and Family Welfare Sep 2021
65. District-Level HIV Estimates and Prioritization in India 2019: Technical Brief, National AIDS Control Organisation & ICMR-National Institute of Medical Statistics (2021). District-Level HIV Estimates and Prioritization in India 2019: Technical Brief. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. untitled (naco.gov.in)

66. India HIV Estimates 2020: Technical Brief National AIDS Control Organisation & ICMR-National Institute of Medical Statistics (2021). District-Level HIV Estimates and Prioritization in India 2019: Technical Brief. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. untitled (naco.gov.in)

67. Reopening Schools After COVID-19 Closures, Lancet COVID Commission, Published on website April 2021

https://static1.squarespace.com/static/5ef3652ab722df11fcb2ba5d/t/60a3cff2b425ae21a5b49405/1621348340073/India+TF+Reopening+Schools+April+2021.pdf

68. Country-wide Containment Strategies for Reducing COVID-19 Cases in India, Lancet COVID Commission, Published on website April 2021

https://static1.squarespace.com/static/5ef3652ab722df11fcb2ba5d/t/60a3cf08d1c1f24480a44c19/1621348107249/India+TF+Country-wide+Containment+Strategies+April+2021.pdf

69. Checklist: Containment Strategies for Reducing COVID-19 Cases in India , Lancet COVID Commission, Published on website April 2021

https://static1.squarespace.com/static/5ef3652ab722df11fcb2ba5d/t/60a3ce9b7e2b69785d33f6e0/1621347995814/India+TF+Checklist+April+2021.pdf

70. In country Data Validation, Elimination of Mother-to-Child Transmission of HIV and Syphilis. A Report Commissioned by National AIDS Control Organization (NACO) Ministry of Health and Family Welfare  2017 [Primary Author]
71. National HIV Counseling and Testing Services (HCTS) Guidelines [Writing Team]
72. India HIV Estimations 2017 Technical Report, National AIDS Control Organization & ICMR-National Institute of Medical Statistics Ministry of Health & Family Welfare Government of India
73. HIV Sentinel Surveillance 2016-17 Technical Brief, December 2017 National AIDS Control Organization [ Regional Team Leader]
74. National Integrated Biological and Behavioural Surveillance (IBBS) 2014-15, High Risk Groups in India
75. Report on INDO-US Joint Workshop on “HIV Database and Cancer Registry Match”
76. Newer Methods of HIV Prevention- Training Module in the one Year HIV Management Certificate Course offered by IGNOU [Author]

Gene Sequences submitted to and published in NCBI gene bank:

Neisseria Gonorrhoeae: gyrA, parC, mtrR sequences

gyr A: NCBI accession number: KY347918 - KY348041,14-12-16

par C: NCBI accession number: KY348042 - KY348165, 14-12-16

mtrR :NCBI accession number: KY348166 - KY348289, 14-12-16